Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model – FirstWord Pharma
Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model FirstWord Pharma Article Source https://firstwordpharma.com/story/5951809
Tag: FirstWord
Google launches TxGemma, a new AI tool for drug discovery – FirstWord Pharma
Google launches TxGemma, a new AI tool for drug discovery FirstWord Pharma Article Source https://firstwordpharma.com/story/5943015
Amazon and Memorial Sloan Kettering Cancer Center leap toward AI-driven drug discovery – FirstWord Pharma
Amazon and Memorial Sloan Kettering Cancer Center leap toward AI-driven drug discovery FirstWord Pharma Article Source https://firstwordpharma.com/story/5936159
Abcuro draws $200M to push muscle weakness drug over the finish line – FirstWord Pharma
Abcuro draws $200M to push muscle weakness drug over the finish line FirstWord Pharma Article Source https://firstwordpharma.com/story/5934611
Servier and Google Cloud commit to five more years of AI-powered R&D – FirstWord Pharma
Servier and Google Cloud commit to five more years of AI-powered R&D FirstWord Pharma Article Source https://firstwordpharma.com/story/5928632